Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139


Physical activity does not alter prolactin levels in post-menopausal women: results from a dose-response randomized controlled trial.

Brenner DR, Ruan Y, Morielli AR, Courneya KS, Friedenreich CM.

Eur Rev Aging Phys Act. 2017 Jul 13;14:10. doi: 10.1186/s11556-017-0179-1. eCollection 2017.


High Ki-67 expression is associated with prolactin secreting pituitary adenomas.

Bălinişteanu B, Cîmpean AM, Ceauşu AR, Corlan AS, Melnic E, Raica M.

Bosn J Basic Med Sci. 2017 May 20;17(2):104-108. doi: 10.17305/bjbms.2017.1750.


Breast carcinoma associated with prolactinoma: A case report.

Zheng Y, Mo W, Yu Y, Zou D, He X, Xia X, Hu J.

Cancer Biol Ther. 2017 Mar 4;18(3):132-136. doi: 10.1080/15384047.2017.1294284. Epub 2017 Feb 17.


Chemoprevention of Rat Mammary Carcinogenesis by Apiaceae Spices.

Aqil F, Jeyabalan J, Munagala R, Ravoori S, Vadhanam MV, Schultz DJ, Gupta RC.

Int J Mol Sci. 2017 Feb 16;18(2). pii: E425. doi: 10.3390/ijms18020425.


Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells.

Barcus CE, O'Leary KA, Brockman JL, Rugowski DE, Liu Y, Garcia N, Yu M, Keely PJ, Eliceiri KW, Schuler LA.

Breast Cancer Res. 2017 Jan 19;19(1):9. doi: 10.1186/s13058-017-0801-1.


The prolactin receptor is expressed in rheumatoid arthritis and psoriatic arthritis synovial tissue and contributes to macrophage activation.

Tang MW, Reedquist KA, Garcia S, Fernandez BM, Codullo V, Vieira-Sousa E, Goffin V, Reuwer AQ, Twickler MT, Gerlag DM, Tak PP.

Rheumatology (Oxford). 2016 Dec;55(12):2248-2259. Epub 2016 Sep 10.


Prolactin Pro-Differentiation Pathway in Triple Negative Breast Cancer: Impact on Prognosis and Potential Therapy.

López-Ozuna VM, Hachim IY, Hachim MY, Lebrun JJ, Ali S.

Sci Rep. 2016 Aug 2;6:30934. doi: 10.1038/srep30934.


Prolactin signaling through focal adhesion complexes is amplified by stiff extracellular matrices in breast cancer cells.

Barcus CE, Keely PJ, Eliceiri KW, Schuler LA.

Oncotarget. 2016 Jul 26;7(30):48093-48106. doi: 10.18632/oncotarget.10137.


Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer.

Qu Q, Zeng F, Liu X, Wang QJ, Deng F.

Cell Death Dis. 2016 May 19;7:e2226. doi: 10.1038/cddis.2016.132. Review.


Plasma prolactin and breast cancer risk: a meta- analysis.

Wang M, Wu X, Chai F, Zhang Y, Jiang J.

Sci Rep. 2016 May 17;6:25998. doi: 10.1038/srep25998.


Prolactin Signaling Stimulates Invasion via Na(+)/H(+) Exchanger NHE1 in T47D Human Breast Cancer Cells.

Pedraz-Cuesta E, Fredsted J, Jensen HH, Bornebusch A, Nejsum LN, Kragelund BB, Pedersen SF.

Mol Endocrinol. 2016 Jul;30(7):693-708. doi: 10.1210/me.2015-1299. Epub 2016 May 13.


Antidepressant use and circulating prolactin levels.

Reeves KW, Okereke OI, Qian J, Tworoger SS, Rice MS, Hankinson SE.

Cancer Causes Control. 2016 Jul;27(7):853-61. doi: 10.1007/s10552-016-0758-x. Epub 2016 May 10.


Targeting Prolactin Receptor (PRLR) Signaling in PRLR-Positive Breast and Prostate Cancer.

O'Sullivan CC, Bates SE.

Oncologist. 2016 May;21(5):523-6. doi: 10.1634/theoncologist.2016-0108. Epub 2016 Apr 22. No abstract available.


Prolactin Inhibits BCL6 Expression in Breast Cancer Cells through a MicroRNA-339-5p-Dependent Pathway.

Yan H, Zhao M, Huang S, Chen P, Wu WY, Huang J, Wu ZS, Wu Q.

J Breast Cancer. 2016 Mar;19(1):26-33. doi: 10.4048/jbc.2016.19.1.26. Epub 2016 Mar 25.


GHR/PRLR Heteromultimer Is Composed of GHR Homodimers and PRLR Homodimers.

Liu Y, Zhang Y, Jiang J, Lobie PE, Paulmurugan R, Langenheim JF, Chen WY, Zinn KR, Frank SJ.

Mol Endocrinol. 2016 May;30(5):504-17. doi: 10.1210/me.2015-1319. Epub 2016 Mar 22.


Synergistic Activation of ERα by Estrogen and Prolactin in Breast Cancer Cells Requires Tyrosyl Phosphorylation of PAK1.

Oladimeji P, Skerl R, Rusch C, Diakonova M.

Cancer Res. 2016 May 1;76(9):2600-11. doi: 10.1158/0008-5472.CAN-15-1758. Epub 2016 Mar 4.


Peptidylarginine Deiminase 3 (PAD3) Is Upregulated by Prolactin Stimulation of CID-9 Cells and Expressed in the Lactating Mouse Mammary Gland.

Li G, Hayward IN, Jenkins BR, Rothfuss HM, Young CH, Nevalainen MT, Muth A, Thompson PR, Navratil AM, Cherrington BD.

PLoS One. 2016 Jan 22;11(1):e0147503. doi: 10.1371/journal.pone.0147503. eCollection 2016.


Depression, Antidepressant Use, and Postmenopausal Breast Cancer Risk.

Brown SB, Hankinson SE, Arcaro KF, Qian J, Reeves KW.

Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):158-64. doi: 10.1158/1055-9965.EPI-15-1063. Epub 2015 Nov 17.

Supplemental Content

Support Center